What Vitiligo Really Is
Vitiligo isn’t just a skin color change. It’s an autoimmune condition where the body’s immune system attacks melanocytes - the cells that make pigment. This leads to white patches on the skin, often starting around the eyes, mouth, hands, or armpits. About 1 in 50 people worldwide have it, with higher rates in India and parts of Africa. The patches don’t hurt or itch, but they can change how people see themselves. For many, the emotional impact is worse than the physical one.
Phototherapy: The Gold Standard for Repigmentation
Phototherapy is the most proven way to bring back color in vitiligo patches. It doesn’t cure the condition, but it helps the body regrow pigment where it’s been lost. The most common type is narrowband ultraviolet B (NB-UVB), which uses a specific wavelength of light (311-313 nm) to trigger melanocytes to wake up and start making pigment again.
Unlike older methods, NB-UVB doesn’t require taking pills or applying chemicals before light exposure. You just stand in a light booth for seconds to minutes, two or three times a week. Most people start seeing results after 2-3 months, but full results take 6-12 months. Facial skin responds best - up to 80% of people see strong repigmentation there. Hands and feet? Not so much. Only about 15-20% see any change, even after a year of treatment.
The light works in two ways: it calms down the immune attack on melanocytes and wakes up dormant ones hiding in hair follicles. This is why hair growing through a white patch often turns dark first - those follicles are the source of new pigment.
Why Phototherapy Isn’t Combined With Depigmentation
There’s a big misunderstanding in the title: phototherapy and depigmentation aren’t used together. They’re opposites.
Phototherapy tries to restore color. Depigmentation does the opposite - it removes the remaining color from normal skin to match the white patches. This is only done when more than 80% of the body is affected. It’s not a first-line treatment. It’s a last resort for people who’ve tried everything else and are tired of fighting uneven skin tone.
Trying to do both at the same time makes no sense. You can’t simultaneously bring color back and take it away. The two approaches are chosen based on how much of your skin is affected - not combined.
How Phototherapy Compares to Other Options
| Method | Wavelength | Frequency | Best For | Response Rate (6-12 months) | Major Risks |
|---|---|---|---|---|---|
| Narrowband UVB (NB-UVB) | 311-313 nm | 2-3 times/week | Generalized vitiligo (>5% body) | 57% achieve ≥50% repigmentation | Mild sunburn, dry skin |
| PUVA | UVA + psoralen | 2-3 times/week | Older patients, resistant cases | 40-45% achieve ≥50% repigmentation | Nausea, 13x higher skin cancer risk |
| Excimer Laser | 308 nm | 1-2 times/week | Small patches (<10% body) | 65% achieve ≥50% repigmentation | Burns if misused, expensive |
NB-UVB is now the go-to because it’s safer and just as effective as PUVA, which uses a light-sensitizing drug called psoralen. PUVA increases the risk of nausea and long-term skin cancer. Excimer lasers are great for small areas - like a patch on your finger - but they’re too slow and costly for full-body use.
Combining Phototherapy With Topical Treatments
The real game-changer isn’t combining phototherapy with depigmentation - it’s combining it with topical creams.
Doctors now routinely pair NB-UVB with calcineurin inhibitors like tacrolimus or pimecrolimus. These creams, usually used for eczema, help calm the immune system right where the light is working. Studies show this combo boosts repigmentation by 25-30% compared to light alone.
Even newer is the combination with ruxolitinib cream (Opzelura), an FDA-approved JAK inhibitor. A 2023 trial showed that using ruxolitinib with NB-UVB led to 54% of patients getting over 50% repigmentation in just six months - compared to 32% with light alone. That’s a big jump. It means fewer sessions, faster results, and better outcomes on hard-to-treat areas like fingers and lips.
These topical treatments don’t replace phototherapy. They make it work better. Think of it like adding fertilizer to sunlight - the light gives the signal, the cream helps the cells respond.
Home vs. Clinic Phototherapy
Most people start in a dermatologist’s office. But home devices are becoming more common. Philips TL-01 and other FDA-cleared units cost between $2,500 and $5,000 upfront. Medicare covers 80% of the cost for qualifying patients since 2021.
Home units have a big advantage: convenience. A 2020 study found 82% of people using home devices completed over 80% of their sessions. In clinics, only about 50% stick with it long-term. Why? Travel time, work schedules, childcare. Missing even one session a week slows progress.
But there’s a catch: 22% more home users get mild burns because they misjudge the dose. That’s why newer devices like Vitilux AI (cleared in October 2023) use smartphone photos to calculate the exact light dose needed. It cuts dosing errors by 37%.
What to Expect During Treatment
First visit: You’ll get a skin test to find your minimal erythema dose (MED) - the lowest amount of UV that causes slight redness. This sets your starting dose. Sessions start short - sometimes just 10 seconds - and slowly increase by 10-20% each week.
You’ll need to wear UV-blocking goggles. Men should shield their genitals. No sunscreen on the patches - you want the light to hit them directly.
After 3-4 months, you’ll start seeing tiny dots of color returning, especially around hair follicles. That’s a good sign. It means the melanocytes are waking up.
Don’t expect miracles on your hands or feet. Those areas are stubborn. If you’ve been treating them for 12 months and see no change, talk to your doctor about switching focus. Pushing harder won’t help - it just adds burn risk.
Why People Quit - And How to Stay On Track
Most people quit because it’s a long haul. 68% of users in one Reddit survey missed at least a quarter of their sessions. The biggest reasons? Time and distance.
Here’s what works for those who stick with it:
- Use a phone app to track sessions - UC Davis Health found 92% adherence with tracking tools.
- Book appointments the same days each week - make it a habit.
- Don’t skip sessions because you’re “not seeing results yet.” The JAMA meta-analysis says you need at least 6 months to judge if it’s working.
- Join a support group. Vitiligo Support International has over 15,000 members sharing tips and encouragement.
Some people feel discouraged when their face improves but their hands don’t. That’s normal. Focus on what’s working. Even small wins - like color returning to your lips or eyelids - can restore confidence.
What’s Next in Vitiligo Treatment
Research is moving fast. The VITCURE-2 trial, launching in early 2024, is testing afamelanotide implants - tiny rods under the skin that boost melanin production. Early results suggest they could cut phototherapy time in half.
Scientists are also looking at genetic markers to predict who responds best to which treatment. In the future, your treatment plan might be based on your DNA, not just your skin.
For now, the best approach is simple: NB-UVB plus a topical cream, done consistently. It’s not glamorous. It takes time. But for most people, it’s the most reliable path to getting color back.
Frequently Asked Questions
Can phototherapy cure vitiligo?
No, phototherapy doesn’t cure vitiligo. It helps restore pigment in depigmented areas, but the underlying autoimmune process continues. Many people see significant repigmentation, especially on the face and neck, but results vary. Maintenance treatments may be needed to keep color stable.
How long does it take to see results from phototherapy?
Most people start seeing small changes after 2-3 months, but meaningful repigmentation usually takes 6-12 months. The 2017 JAMA Dermatology study confirmed that 6 months is the minimum time needed to judge if phototherapy is working. Don’t give up before then.
Is home phototherapy as effective as clinic treatments?
Yes - when used correctly. A 2020 study found home phototherapy was just as effective as clinic sessions, with 78% of users achieving over 50% repigmentation versus 82% in clinics. The big advantage? Better adherence. People using home devices miss fewer sessions because they don’t have to travel.
Why doesn’t phototherapy work on hands and feet?
The skin on hands and feet has fewer hair follicles, and melanocytes in those areas are harder to activate. Even after 12 months of treatment, only 15-20% of people see noticeable repigmentation there. For these areas, doctors often recommend combining phototherapy with topical JAK inhibitors like ruxolitinib to improve results.
Are there any long-term risks with NB-UVB phototherapy?
Long-term studies, including 15-year follow-ups published in the British Journal of Dermatology, show no increased risk of melanoma with NB-UVB. The main risks are mild sunburn and dry skin. This is why proper dosing and avoiding overexposure are critical. PUVA, not NB-UVB, carries a higher skin cancer risk.
Can children and pregnant women use phototherapy?
Yes. NB-UVB is considered safe for children and is the most common treatment for pediatric vitiligo. It’s also classified as Category B by the FDA for use during pregnancy - meaning no evidence of harm to the fetus. Topical creams like tacrolimus are also considered safe in pregnancy when used as directed.
11 Comments